Envoy Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Envoy Medical
COCH Stock   0.52  0.14  21.21%   
Envoy Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Envoy Medical's valuation are provided below:
Gross Profit
-612 K
Market Capitalization
19.1 M
Enterprise Value Revenue
41.705
Revenue
208 K
Earnings Share
(1.37)
We have found one hundred twenty available fundamental signals for Envoy Medical, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Envoy Medical prevailing fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year.

Envoy Medical Total Revenue

217,600

Check Envoy Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Envoy Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 105.3 K, Other Operating Expenses of 11.9 M or Total Operating Expenses of 11.3 M, as well as many indicators such as Price To Sales Ratio of 258, Dividend Yield of 0.0729 or Days Sales Outstanding of 1.3 K. Envoy financial statements analysis is a perfect complement when working with Envoy Medical Valuation or Volatility modules.
  
Build AI portfolio with Envoy Stock
Check out the analysis of Envoy Medical Correlation against competitors.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.

Envoy Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets13.9 M13.3 M3.1 M
Slightly volatile
Total Current Liabilities9.1 M8.7 M2.2 M
Slightly volatile
Accounts Payable1.1 M1.9 M524.4 K
Slightly volatile
Cash6.6 M6.3 M1.4 M
Slightly volatile
Non Current Assets Total2.6 M2.5 M599.3 K
Slightly volatile
Cash And Short Term Investments6.6 M6.3 M1.4 M
Slightly volatile
Common Stock Shares Outstanding17.9 M16.9 M44.2 M
Slightly volatile
Liabilities And Stockholders Equity13.9 M13.3 M3.1 M
Slightly volatile
Other Stockholder Equity192.6 M305.9 M80.8 M
Slightly volatile
Total Liabilities27.9 M34.9 M11.2 M
Slightly volatile
Total Current Assets11.3 M10.8 M2.5 M
Slightly volatile
Common Stock1.7 K1.8 K83.2 K
Pretty Stable
Short and Long Term Debt Total15.6 M17.7 M21.8 M
Slightly volatile
Other Liabilities2 M2 M2.6 M
Slightly volatile
Property Plant And Equipment Net2.6 M2.5 M659.5 K
Slightly volatile
Long Term Debt20.2 M16.8 M22.9 M
Slightly volatile
Net Receivables987.7 K940.7 K230.2 K
Slightly volatile
Non Current Liabilities Total21.6 M20.6 M38.7 M
Slightly volatile
Inventory1.5 M2 M1.2 M
Slightly volatile
Other Current Assets944.6 K1.6 M458.7 K
Slightly volatile
Property Plant And Equipment Gross6.2 M8 M5.2 M
Slightly volatile
Capital Stock1.7 K1.8 K1.1 M
Slightly volatile
Short Term Debt122.3 K128.7 K390.9 K
Slightly volatile
Property Plant Equipment602.8 K1 M389.8 K
Slightly volatile
Short and Long Term Debt358.4 K403.2 K440.1 K
Slightly volatile
Other Assets0.80.90.9824
Slightly volatile
Non Current Liabilities Other712.8 K801.9 K875.3 K
Slightly volatile

Envoy Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization105.3 K155.7 K175.4 K
Slightly volatile
Other Operating Expenses11.9 M22.4 M5.2 M
Slightly volatile
Total Operating Expenses11.3 M21.5 M5 M
Slightly volatile
Selling General Administrative5.3 M7.8 M3.5 M
Slightly volatile
Total Revenue217.6 K202.5 K289.3 K
Slightly volatile
Research Development7.7 M11.7 M5.3 M
Slightly volatile
Cost Of Revenue769.5 K853.3 K757.6 K
Very volatile
Reconciled Depreciation118.2 K198.9 K89.9 K
Slightly volatile
Selling And Marketing Expenses1.6 M2 M1.1 M
Slightly volatile

Envoy Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Change In Cash1.7 M1.5 M1.2 M
Slightly volatile
Net Borrowings12.2 M21.9 M9.8 M
Slightly volatile
Begin Period Cash Flow5.1 M4.9 M947.2 K
Slightly volatile
Other Cashflows From Financing Activities982.2 K1 M908.2 K
Slightly volatile
Depreciation124.3 K198.9 K91.5 K
Slightly volatile
Other Non Cash Items7.2 M5.7 M3.4 M
Slightly volatile
Capital Expenditures1.2 M1.1 M303.6 K
Slightly volatile
Total Cash From Financing Activities15.8 M23.2 M10.9 M
Slightly volatile
End Period Cash Flow6.6 M6.3 M2.1 M
Slightly volatile
Other Cashflows From Investing Activities340 M382.5 M417.5 M
Slightly volatile
Change To Netincome4.9 M8.3 M3.3 M
Slightly volatile
Change To Liabilities312.9 K393.3 K262.1 K
Slightly volatile
Sale Purchase Of Stock50.4 K56.7 K61.9 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio258137285
Slightly volatile
Dividend Yield0.07290.0820.0895
Slightly volatile
Days Sales Outstanding1.3 K1.2 K304
Slightly volatile
Average Payables302.7 K340.5 K371.7 K
Slightly volatile
Stock Based Compensation To Revenue3.984.494.896
Slightly volatile
Capex To Depreciation5.355.12.4293
Slightly volatile
EV To Sales332210356
Slightly volatile
Inventory Turnover0.580.50.6569
Slightly volatile
Days Of Inventory On Hand588756578
Slightly volatile
Payables Turnover0.720.520.9797
Slightly volatile
Sales General And Administrative To Revenue14.4427.311.8648
Slightly volatile
Research And Ddevelopement To Revenue21.4640.7218.19
Slightly volatile
Capex To Revenue4.123.921.0964
Slightly volatile
Cash Per Share0.280.260.0765
Slightly volatile
Days Payables Outstanding516731428
Slightly volatile
Income Quality0.540.720.7517
Slightly volatile
Current Ratio0.791.120.5569
Slightly volatile
Receivables Turnover0.30.323.1449
Slightly volatile
Capex Per Share0.04930.04690.0194
Slightly volatile
Revenue Per Share0.02510.01380.0274
Slightly volatile
Interest Debt Per Share1.881.252.083
Slightly volatile
Debt To Assets1.861.967.4393
Slightly volatile
Operating Cycle2 K2 K893
Slightly volatile
Days Of Payables Outstanding516731428
Slightly volatile
Ebt Per Ebit1.61.241.3253
Slightly volatile
Quick Ratio0.520.920.4292
Slightly volatile
Cash Ratio0.390.650.359
Slightly volatile
Cash Conversion Cycle1.3 K1.2 K450
Slightly volatile
Days Of Inventory Outstanding588756578
Slightly volatile
Days Of Sales Outstanding1.3 K1.2 K304
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.820.951.0044
Slightly volatile
Fixed Asset Turnover0.110.121.2218
Slightly volatile
Debt Ratio1.861.967.4393
Slightly volatile
Price Sales Ratio258137285
Slightly volatile
Asset Turnover0.02130.02240.0948
Slightly volatile

Envoy Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap18.2 M20.5 M22.3 M
Slightly volatile
Enterprise Value15.3 M17.2 M18.7 M
Slightly volatile

Envoy Fundamental Market Drivers

Envoy Upcoming Events

16th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
16th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Envoy Medical Financial Statements

Investors use fundamental indicators, such as Envoy Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Envoy Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue-142.2 K-135.1 K
Total Revenue202.5 K217.6 K
Cost Of Revenue853.3 K769.5 K
Stock Based Compensation To Revenue 4.49  3.98 
Sales General And Administrative To Revenue 27.30  14.44 
Research And Ddevelopement To Revenue 40.72  21.46 
Capex To Revenue 3.92  4.12 
Revenue Per Share 0.01  0.03 
Ebit Per Revenue(98.42)(103.34)

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Envoy Medical is a strong investment it is important to analyze Envoy Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Envoy Medical's future performance. For an informed investment choice regarding Envoy Stock, refer to the following important reports:
How To Invest In Envoy
Details
Is Envoy Stock a good investment?
Details
What is Envoy Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Envoy Medical Correlation against competitors.
For more detail on how to invest in Envoy Stock please use our How to Invest in Envoy Medical guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is there potential for Health Care Equipment & Supplies market expansion? Will Envoy introduce new products? Factors like these will boost the valuation of Envoy Medical. Projected growth potential of Envoy fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Envoy Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.37)
Revenue Per Share
0.01
Quarterly Revenue Growth
(0.25)
Return On Assets
(1.45)
Understanding Envoy Medical requires distinguishing between market price and book value, where the latter reflects Envoy's accounting equity. The concept of intrinsic value - what Envoy Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Envoy Medical's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Envoy Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Envoy Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Envoy Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY